Increases in serum total low-density lipoprotein (LDL)

Also known as: Increased LDL / Increased Low-Density Lipoprotein Cholesterol / Increases in low density lipoprotein / Low density lipoprotein increased / Increased low-density lipoprotein / Increased serum levels of low-density lipoproteins / Increased low density lipoprotein cholesterol / LDL increased / Increase in LDL cholesterol / Increase in low-density lipoprotein cholesterol / Increased low density lipoproteins / Increased serum levels of low-density lipoprotein / Increase in low density lipoprotein cholesterol / LDL raised / Raised LDL / LDL inc / LDL cholesterol increased / Low density lipoprotein cholesterol increased / Low density lipoprotein cholesterol high

DrugDrug NameDrug Description
DB09303EvolocumabA PCSK9 (proprotein convertase subtilisin kexin type 9) inhibitor antibody used as an adjunct to LDL cholesterol reducing therapies, aiding in the prevention of cardiovascular events and cardiovascular revascularization procedures.
DB08860PitavastatinAn HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke.
DrugDrug NamePhaseStatusCount